Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and Anhedonia

aripiprazole has been researched along with Anhedonia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adham, N; Banasr, M; Duman, RS; Duric, V; Franklin, T; Gyertyán, I; Kiss, B; Lepack, A1
De Montis, MG; Gambarana, C; Pelliccia, T; Scheggi, S1
Allen, TA; Frey, BN; Kennedy, SH; Lam, RW; MacQueen, GM; Milev, R; Müller, DJ; Quilty, LC; Rizvi, SJ; Uher, R1
Adham, N; Gruca, P; Gyertyán, I; Kiss, B; Lasoń-Tyburkiewicz, M; Papp, M1
Bobmanuel, S; Davies, W; Dratcu, L; Farmer, A; George, M; Rana, T; Singh, M; Turner, M1

Other Studies

5 other study(ies) available for aripiprazole and Anhedonia

ArticleYear
Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
    The international journal of neuropsychopharmacology, 2017, 10-01, Volume: 20, Issue:10

    Topics: Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Aripiprazole; Chronic Disease; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Imipramine; Male; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Receptors, Dopamine D3; Stress, Psychological; Uncertainty

2017
Aripiprazole relieves motivational anhedonia in rats.
    Journal of affective disorders, 2018, Volume: 227

    Topics: Anhedonia; Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine and cAMP-Regulated Phosphoprotein 32; Male; Motivation; Nucleus Accumbens; Phosphorylation; Rats; Reward; Self Administration; Sucrose

2018
Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report.
    Psychological medicine, 2019, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Anhedonia; Antidepressive Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Punishment; Reward; Young Adult

2019
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression.
    Behavioural pharmacology, 2014, Volume: 25, Issue:5-6

    Topics: Anhedonia; Animals; Antidepressive Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Imipramine; Male; Piperazines; Quinolones; Rats, Wistar; Stress, Psychological

2014
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.
    International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:4

    Topics: Acute Disease; Anhedonia; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Metabolic Diseases; Patient Participation; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Recovery of Function; Sexual Dysfunction, Physiological; Treatment Outcome

2012